Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Cancer
-
Rifamycin AMI-DA
CAS 17096-02-5 AG-CN2-0330 AG-CN2-0330-M010 10 mg CHF 150.00AG-CN2-0330-M050 50 mg CHF 600.00
-
Rifamycin AMP-DA
CAS 16783-99-6 AG-CN2-0331 AG-CN2-0331-M010 10 mg CHF 150.00AG-CN2-0331-M050 50 mg CHF 600.00
-
Rifamycin M14
CAS 2750-76-7 AG-CN2-0332 AG-CN2-0332-M010 10 mg CHF 110.00AG-CN2-0332-M050 50 mg CHF 440.00
-
Rifamycin O
CAS 14487-05-9 AG-CN2-0333 AG-CN2-0333-M050 50 mg CHF 90.00AG-CN2-0333-M500 500 mg CHF 490.00
-
Rifamycin PR-14
CAS 21240-38-0 AG-CN2-0334 AG-CN2-0334-M010 10 mg CHF 150.00AG-CN2-0334-M050 50 mg CHF 600.00
-
Rifamycin PR-3
CAS 21288-98-2 AG-CN2-0335 AG-CN2-0335-M010 10 mg CHF 120.00AG-CN2-0335-M050 50 mg CHF 480.00
-
Rifamycin S, 8-Methyl-
CAS 42898-13-5 AG-CN2-0337 AG-CN2-0337-M010 10 mg CHF 150.00AG-CN2-0337-M050 50 mg CHF 600.00
-
-
Ruxolitinib (free base)
CAS 941678-49-5 AG-CR1-3624 AG-CR1-3624-M005 5 mg CHF 80.00AG-CR1-3624-M025 25 mg CHF 180.00AG-CR1-3624-M100 100 mg CHF 360.00
-
Ruxolitinib . phosphate salt
CAS 1092939-17-7 AG-CR1-3645 AG-CR1-3645-M005 5 mg CHF 50.00AG-CR1-3645-M025 25 mg CHF 120.00AG-CR1-3645-M100 100 mg CHF 250.00